Key Points
- Director Judd Dayton bought 18,097 shares on Feb 27 at $4.63 (plus earlier buys of 10,500 on Mar 2 at $4.53 and 4,600 on Feb 26 at $4.58), increasing his position ~34.96% to 69,859 shares valued at about $323,447.
- Lifevantage shares have weakened (recently down 2.8%), trading near $4.52 with a market cap of ~$57.8M and a PE of 7.53; the company missed Q results (EPS $0.15 vs. $0.22 expected) and set FY2026 guidance of $0.60–$0.80 EPS.
- The board declared a quarterly dividend of $0.045 (ex-dividend Mar 2, payable Mar 16), equivalent to a 4.0% yield and a payout ratio of ~30%.
Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) Director Judd Dayton purchased 4,600 shares of the firm's stock in a transaction on Thursday, February 26th. The shares were acquired at an average price of $4.58 per share, with a total value of $21,068.00. Following the purchase, the director directly owned 51,762 shares in the company, valued at $237,069.96. This represents a 9.75% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Judd Dayton also recently made the following trade(s):
- On Monday, March 2nd, Judd Dayton acquired 10,500 shares of Lifevantage stock. The stock was acquired at an average cost of $4.53 per share, for a total transaction of $47,565.00.
- On Friday, February 27th, Judd Dayton acquired 18,097 shares of Lifevantage stock. The shares were acquired at an average price of $4.63 per share, with a total value of $83,789.11.
Lifevantage Price Performance
NASDAQ:LFVN opened at $4.52 on Tuesday. Lifevantage Corporation has a one year low of $3.90 and a one year high of $17.64. The company has a market cap of $57.81 million, a PE ratio of 7.53 and a beta of 0.36. The firm has a 50-day moving average of $5.62 and a 200-day moving average of $7.86.
Lifevantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.07). The company had revenue of $48.93 million for the quarter, compared to analyst estimates of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.
Lifevantage Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.18 annualized dividend and a dividend yield of 4.0%. Lifevantage's payout ratio is presently 30.00%.
Hedge Funds Weigh In On Lifevantage
A number of hedge funds and other institutional investors have recently made changes to their positions in LFVN. Capital Management Corp VA increased its holdings in Lifevantage by 63.0% during the third quarter. Capital Management Corp VA now owns 2,064,176 shares of the company's stock worth $20,084,000 after buying an additional 798,066 shares during the last quarter. Los Angeles Capital Management LLC purchased a new stake in shares of Lifevantage during the 2nd quarter worth approximately $288,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Lifevantage in the 2nd quarter worth approximately $784,000. AlphaQuest LLC lifted its stake in Lifevantage by 12,659.7% in the second quarter. AlphaQuest LLC now owns 7,911 shares of the company's stock valued at $103,000 after purchasing an additional 7,849 shares during the last quarter. Finally, Jane Street Group LLC grew its holdings in Lifevantage by 5.4% during the first quarter. Jane Street Group LLC now owns 36,567 shares of the company's stock valued at $533,000 after purchasing an additional 1,877 shares during the period. 35.32% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several brokerages have weighed in on LFVN. Lake Street Capital restated a "buy" rating on shares of Lifevantage in a research note on Thursday, February 5th. Weiss Ratings reiterated a "hold (c)" rating on shares of Lifevantage in a report on Monday, December 29th. Wall Street Zen cut shares of Lifevantage from a "buy" rating to a "hold" rating in a report on Saturday, November 8th. Finally, Loop Capital set a $5.00 price objective on shares of Lifevantage in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Lifevantage has a consensus rating of "Moderate Buy" and a consensus target price of $5.00.
View Our Latest Stock Analysis on LFVN
Lifevantage Company Profile
(
Get Free Report)
LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.
Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
